-
Dual-Action Inhibitors and p38α Dephosphorylation
2026-09-11
The reference study shows that selected p38α kinase inhibitors can do more than block catalytic activity: they can also accelerate WIP1-mediated removal of the activation-loop phosphate. Structural and biochemical evidence links this effect to an inhibitor-stabilized activation-loop conformation, suggesting a strategy for designing kinase inhibitors that promote target-selective dephosphorylation.
-
Deferoxamine Mesylate: Iron Biology Guide
2026-09-11
Deferoxamine mesylate is an iron-chelating agent for controlling labile iron, oxidative stress, and hypoxia-linked signaling in research assays. Product information supports applications in iron metabolism, HIF-1α stabilization, tumor growth inhibition in breast cancer models, wound healing promotion, and tissue-protection studies, while the cited ESCC study provides mechanistic context rather than direct evidence for deferoxamine.
-
Palmitic acid: Practical Protocol & QC Guide
2026-09-10
Palmitic acid (SKU N2456) provides a defined hexadecanoic acid input for solvent-controlled studies of lipid metabolism, inflammation, and cellular signaling. It is appropriate for ethanol- or DMSO-based workflows, but not for aqueous-only assays or long-term storage of prepared solutions.
-
Leptin (116-130), amide, mouse Workflows
2026-09-10
Leptin (116-130), amide, mouse provides a defined peptide stimulus for probing energy homeostasis regulation, leptin resistance, and immunometabolic responses. This practical guide combines solvent handling, dose–time optimization, comparator controls, and a cautious extension of recent SIRT6–AMPK–NLRP3 research.
-
MTT for Cell Viability and Fibrosis Research
2026-09-09
Use MTT to quantify treatment-associated changes in cellular metabolic activity, proliferation, and apparent viability in reproducible plate-based workflows. This guide translates the quercetin–miR-223-3p/FOXO3 findings into practical assay design while showing how controls, normalization, and troubleshooting prevent misleading colorimetric results.
-
GM 6001 for ECM and Alzheimer’s Research
2026-09-09
GM 6001 (Galardin) provides broad MMP inhibition for linking extracellular-matrix remodeling with neural, tissue-repair, cancer, and vascular phenotypes. This practical guide covers stock preparation, assay design, interpretation, and troubleshooting while translating recent perineuronal-net findings into reproducible workflows.
-
SB 431542: Practical ALK5 Inhibitor Workflows
2026-09-08
SB 431542 gives researchers a selective way to interrogate ALK5-dependent TGF-β signaling, from Smad2 target engagement to epithelial-cell expansion and differentiation. This workflow-focused guide translates the lacrimal gland study into practical controls, dose-finding strategies, and troubleshooting steps while distinguishing pathway effects from toxicity.
-
PF-573228 FAK Inhibitor Workflow Guide
2026-09-08
Use PF-573228 to separate matrix-driven FAK signaling from downstream differentiation, migration, and survival phenotypes. This practical guide translates dentinogenesis findings into workflows for mechanobiology, cancer migration, and endothelial assays.
-
Prestained Protein Marker in Resistance Research
2026-09-07
A translational guide to connecting the ARID1A–PTEN–Akt resistance mechanism with reproducible SDS-PAGE and Western blot evidence, using a defined triple-color, EDTA-free protein ladder to strengthen assay interpretation.
-
(S)-(+)-Methoprene Workflows for JH Assays
2026-09-07
Use (S)-(+)-Methoprene to separate juvenile hormone receptor signaling from upstream biosynthesis in developmental, reproductive, and endocrine-disruption assays. This workflow connects Met activation with miRNA–mRNA regulation, vitellogenesis, and insect metamorphosis inhibition.
-
Dual-Action Control of p38α Dephosphorylation
2026-09-05
The reference preprint shows that selected kinase inhibitors can both suppress p38α catalytic activity and accelerate WIP1-mediated removal of the activation-loop phosphothreonine. Biochemical experiments and X-ray structures connect this effect to an inhibitor-stabilized activation-loop conformation, offering a framework for designing kinase inhibitors that promote more complete pathway shutdown.
-
Angiotensin Peptides and SARS-CoV-2 Spike Binding
2026-09-04
The 2025 reference study shows that naturally occurring angiotensin peptide fragments can alter SARS-CoV-2 spike binding to host receptors, with particularly strong effects observed for AXL. Its sequence-focused binding experiments connect renin–angiotensin signaling with viral receptor biology while defining important limits for interpretation and follow-up validation.
-
NLRP10, Keratinocyte Survival, and AD Barrier Function
2026-09-04
The reference study identifies NLRP10 as a functional regulator of human epidermal homeostasis, connecting atopic dermatitis genetics with keratinocyte survival, p63-dependent differentiation, and barrier integrity. Patient tissue analysis and air-lift human skin equivalents show that NLRP10 restrains caspase-8 signaling at the DISC while stabilizing p63, providing a mechanistic framework for barrier failure in atopic dermatitis.
-
Deferoxamine Mesylate at the Ferroptosis Frontier
2026-09-03
Deferoxamine mesylate is more than a conventional iron-chelating agent: it is a translational probe for testing how labile iron, oxidative stress, ferroptosis, and hypoxia signaling interact. This article connects FDXR-related disease biology with practical research design, cancer models, tissue protection, and future biomarker strategies.
-
PCN Suppresses Hippocampal CYP and Neurotoxicity
2026-09-03
A 2025 mouse study reports that Pregnenolone-16α-carbonitrile suppresses hippocampal CYP3A11 and CYP2B10 despite inducing these enzymes in the liver. The protective effect against phenytoin-associated neuronal injury was linked to glucocorticoid receptor signaling rather than the canonical PXR pathway, highlighting tissue-specific interpretation of PCN responses.